Lenalidomide Consolidation Benefits CLL Patients Post Chemoimmunotherapy

Chemoimmunotherapy followed by lenalidomide consolidation is tolerated and extends PFS and OS in CLL patients.

Source: CancerNetwork - August 2, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news